<DOC>
	<DOCNO>NCT00154206</DOCNO>
	<brief_summary>The aim pilot study evaluate efficacy tolerability EC-MPS b.i.d , Cyclosporine microemulsion steroid pediatric de novo renal transplant patient . Safety dose variation also evaluate .</brief_summary>
	<brief_title>Study Enteric-coated Mycophenolate Sodium ( EC-MPS ) With Cyclosporine Microemulsion Steroids Pediatric de Novo Renal Transplant Patients</brief_title>
	<detailed_description />
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Recipients primary renal transplantation Recipients renal transplantation Recipients multiorgan transplantation Unable take oral medication Requiring induction therapy polyclonal , monoclonal antibody ( OKT3 , ATG , ALG ) . Other protocoldefined inclusion / exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Enteric-coated mycophenolate sodium ,</keyword>
	<keyword>de novo ,</keyword>
	<keyword>renal transplantation ,</keyword>
	<keyword>pediatric</keyword>
	<keyword>De novo pediatric renal transplantation</keyword>
</DOC>